SCHEDULE 13G/A: BlackRock Amends Stake in Exact Sciences, Reports 4.3% Passive Ownership

BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 4.3% beneficial ownership stake in Exact Sciences Corp. as of June 30, 2025.

Summary

• BlackRock, Inc. reported beneficial ownership of 8,070,493 shares of Common Stock in EXACT SCIENCES CORP.
• This ownership represents 4.3% of the class of securities.
• BlackRock holds sole voting power over 7,502,047 shares and sole dispositive power over 8,070,493 shares.
• The filing is an Amendment No. 3 to a Schedule 13G, indicating a passive investment intent.
• BlackRock certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Exact Sciences Corp.

Sentiment

Score: 5

Explanation: The document is a factual regulatory filing disclosing an ownership stake, with no explicit positive or negative performance implications for the issuer.

Positives

• The disclosure of a significant stake by a major institutional investor like BlackRock can signal confidence in Exact Sciences Corp. to other investors.
• BlackRock's certification of passive investment intent indicates stability in its holding, not seeking to influence company control.

Risks

• BlackRock, Inc. certifies that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of Exact Sciences Corp., which is a standard regulatory compliance statement for passive investors.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding Exact Sciences Corp.'s future performance or strategic direction.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11."

Industry Context

This filing is a routine disclosure by a large institutional asset manager, BlackRock, Inc., detailing its passive ownership stake in Exact Sciences Corp. It reflects standard investment portfolio management and regulatory compliance within the financial industry.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake and passive investment intent.

Next Steps

• BlackRock, Inc. will continue to file amendments to its Schedule 13G as required by SEC regulations if its beneficial ownership percentage changes significantly or if its investment intent shifts.

Key Dates

Keywords

BlackRock, Exact Sciences, Schedule 13G, beneficial ownership, institutional investment, common stock, passive investment